{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T02:00:23Z","timestamp":1773453623161,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,16]],"date-time":"2021-01-16T00:00:00Z","timestamp":1610755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,16]],"date-time":"2021-01-16T00:00:00Z","timestamp":1610755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01KX2021"],"award-info":[{"award-number":["01KX2021"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Projekt DEAL"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Microbiol Immunol"],"published-print":{"date-parts":[[2021,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Successful containment strategies for the SARS-CoV-2 pandemic will depend on reliable diagnostic assays. Point-of-care antigen tests (POCT) may provide an alternative to time-consuming PCR tests to rapidly screen for acute infections on site. Here, we evaluated two SARS-CoV-2 antigen tests: the STANDARD\u2122 F COVID-19 Ag FIA (FIA) and the SARS-CoV-2 Rapid Antigen Test (RAT). For diagnostic assessment, we used a large set of PCR-positive and PCR-negative respiratory swabs from asymptomatic and symptomatic patients and health care workers in the setting of two University Hospitals in Munich, Germany, i.e. emergency rooms, patient care units or employee test centers. For FIA, overall clinical sensitivity and specificity were 45.4% (<jats:italic>n<\/jats:italic>\u2009=\u2009381) and 97.8% (<jats:italic>n<\/jats:italic>\u2009=\u2009360), respectively, and for RAT, 50.3% (<jats:italic>n<\/jats:italic>\u2009=\u2009445) and 97.7% (<jats:italic>n<\/jats:italic>\u2009=\u2009386), respectively. For primary diagnosis of asymptomatic and symptomatic individuals, diagnostic sensitivities were 60.9% (FIA) (<jats:italic>n<\/jats:italic>\u2009=\u2009189) and 64.5% (RAT) (<jats:italic>n<\/jats:italic>\u2009=\u2009256). This questions these tests\u2019 utility for the reliable detection of acute SARS-CoV-2-infected individuals, in particular in high-risk settings. We support the proposal that convincing high-quality outcome data on the impact of false-negative and false-positive antigen test results need to be obtained in a POCT setting. Moreover, the efficacy of alternative testing strategies to complement PCR assays must be evaluated by independent laboratories, prior to widespread implementation in national and international test strategies.<\/jats:p>","DOI":"10.1007\/s00430-020-00698-8","type":"journal-article","created":{"date-parts":[[2021,1,16]],"date-time":"2021-01-16T08:03:01Z","timestamp":1610784181000},"page":"65-72","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["Evaluation of two rapid antigen tests to detect SARS-CoV-2 in a hospital setting"],"prefix":"10.1007","volume":"210","author":[{"given":"Andreas","family":"Osterman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanna-Mari","family":"Baldauf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marwa","family":"Eletreby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jochen M.","family":"Wettengel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suliman Q.","family":"Afridi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thimo","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Holzmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anton","family":"Maier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna","family":"D\u00f6ring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natascha","family":"Grzimek-Koschewa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maximilian","family":"Muenchhoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrike","family":"Protzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Kaderali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1384-8946","authenticated-orcid":false,"given":"Oliver T.","family":"Keppler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,16]]},"reference":[{"key":"698_CR1","unstructured":"Centers for Disease Control and Prevention (CDC). Information for laboratories about coronavirus (COVID-19). Atlanta: CDC. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/lab\/index.html. Accessed 16 Apr 2020"},{"key":"698_CR2","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.Es.2020.25.3.2000045","author":"VM Corman","year":"2020","unstructured":"Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, Bleicker T, Br\u00fcnink S, Schneider J, Schmidt ML, Mulders DG, Haagmans BL, van der Veer B, van den Brink S, Wijsman L, Goderski G, Romette JL, Ellis J, Zambon M, Peiris M, Goossens H, Reusken C, Koopmans MP, Drosten C (2020) Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. https:\/\/doi.org\/10.2807\/1560-7917.Es.2020.25.3.2000045","journal-title":"Euro Surveill"},{"key":"698_CR3","doi-asserted-by":"publisher","first-page":"104412","DOI":"10.1016\/j.jcv.2020.104412","volume":"128","author":"PB van Kasteren","year":"2020","unstructured":"van Kasteren PB, van der Veer B, van den Brink S, Wijsman L, de Jonge J, van den Brandt A, Molenkamp R, Reusken C, Meijer A (2020) Comparison of seven commercial RT-PCR diagnostic kits for COVID-19. J Clin Virol 128:104412. https:\/\/doi.org\/10.1016\/j.jcv.2020.104412","journal-title":"J Clin Virol"},{"key":"698_CR4","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.Es.2020.25.9.2000173","author":"R Konrad","year":"2020","unstructured":"Konrad R, Eberle U, Dangel A, Treis B, Berger A, Bengs K, Fingerle V, Liebl B, Ackermann N, Sing A (2020) Rapid establishment of laboratory diagnostics for the novel coronavirus SARS-CoV-2 in Bavaria, Germany, February 2020. Euro Surveill. https:\/\/doi.org\/10.2807\/1560-7917.Es.2020.25.9.2000173","journal-title":"Euro Surveill"},{"key":"698_CR5","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.Es.2020.25.24.2001057","author":"M Muenchhoff","year":"2020","unstructured":"Muenchhoff M, Mairhofer H, Nitschko H, Grzimek-Koschewa N, Hoffmann D, Berger A, Rabenau H, Widera M, Ackermann N, Konrad R, Zange S, Graf A, Krebs S, Blum H, Sing A, Liebl B, W\u00f6lfel R, Ciesek S, Drosten C, Protzer U, Boehm S, Keppler OT (2020) Multicentre comparison of quantitative PCR-based assays to detect SARS-CoV-2, Germany, March 2020. Euro Surveill. https:\/\/doi.org\/10.2807\/1560-7917.Es.2020.25.24.2001057","journal-title":"Euro Surveill"},{"key":"698_CR6","unstructured":"World Health Organization (WHO). Coronavirus disease (COVID-19) technical guidance: Laboratory testing for 2019-nCoV in humans. Geneva: WHO. https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/technical-guidance\/laboratory-guidance. Accessed 16 Apr 2020"},{"key":"698_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2020.09.057","author":"B Diao","year":"2020","unstructured":"Diao B, Wen K, Zhang J, Chen J, Han C, Chen Y, Wang S, Deng G, Zhou H, Wu Y (2020) Accuracy of a nucleocapsid protein antigen rapid test in the diagnosis of SARS-CoV-2 infection. Clin Microbiol Infect. https:\/\/doi.org\/10.1016\/j.cmi.2020.09.057. (in press)","journal-title":"Clin Microbiol Infect"},{"key":"698_CR8","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.02338-20","author":"S Young","year":"2020","unstructured":"Young S, Taylor SN, Cammarata CL, Varnado KG, Roger-Dalbert C, Montano A, Griego-Fullbright C, Burgard C, Fernandez C, Eckert K, Andrews JC, Ren H, Allen J, Ackerman R, Cooper CK (2020) Clinical evaluation of BD Veritor SARS-CoV-2 point-of-care test performance compared to PCR-based testing and versus the Sofia 2 SARS Antigen point-of-care test. J Clin Microbiol. https:\/\/doi.org\/10.1128\/jcm.02338-20","journal-title":"J Clin Microbiol"},{"key":"698_CR9","unstructured":"SD Biosensor. COVID-19 Ag FIA, Package Insert. https:\/\/bestbion.com\/wp-content\/uploads\/2020\/11\/bestbiondx_GA_COVID19_FIA_2020111.pdf. Accessed 12 Nov 2020"},{"key":"698_CR10","unstructured":"Roche Diagnostics GmbH. SARS-CoV-2 Rapid Antigen Test, Package Insert. https:\/\/www.roche.de\/res\/content\/11722\/packungsbeilage_sars-cov-2_rapid_antigen_test.pdf. Accessed 12 Nov 2020"},{"key":"698_CR11","unstructured":"Gallup JM (2011) Difficult templates and inhibitors of PCR. PCR troubleshooting and optimization: the essential guide. In: Kennedy S, Oswald N (eds) Caister Academic Press, UK"},{"issue":"7","key":"698_CR12","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.jiph.2020.05.023","volume":"13","author":"J Lin","year":"2020","unstructured":"Lin J, Yan K, Zhang J, Cai T, Zheng J (2020) A super-spreader of COVID-19 in Ningbo city in China. J Infect Public Health 13(7):935\u2013937. https:\/\/doi.org\/10.1016\/j.jiph.2020.05.023","journal-title":"J Infect Public Health"},{"issue":"32","key":"698_CR13","doi-asserted-by":"publisher","first-page":"2001483","DOI":"10.2807\/1560-7917.ES.2020.25.32.2001483","volume":"25","author":"A Singanayagam","year":"2020","unstructured":"Singanayagam A, Patel M, Charlett A, Lopez Bernal J, Saliba V, Ellis J, Ladhani S, Zambon M, Gopal R (2020) Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020. Eurosurveillance 25(32):2001483. https:\/\/doi.org\/10.2807\/1560-7917.ES.2020.25.32.2001483","journal-title":"Eurosurveillance"},{"issue":"28","key":"698_CR14","doi-asserted-by":"publisher","first-page":"16587","DOI":"10.1073\/pnas.2009799117","volume":"117","author":"M Imai","year":"2020","unstructured":"Imai M, Iwatsuki-Horimoto K, Hatta M, Loeber S, Halfmann PJ, Nakajima N, Watanabe T, Ujie M, Takahashi K, Ito M, Yamada S, Fan S, Chiba S, Kuroda M, Guan L, Takada K, Armbrust T, Balogh A, Furusawa Y, Okuda M, Ueki H, Yasuhara A, Sakai-Tagawa Y, Lopes TJS, Kiso M, Yamayoshi S, Kinoshita N, Ohmagari N, Hattori S-i, Takeda M, Mitsuya H, Krammer F, Suzuki T, Kawaoka Y (2020) Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development. Proc Natl Acad Sci 117(28):16587\u201316595. https:\/\/doi.org\/10.1073\/pnas.2009799117","journal-title":"Proc Natl Acad Sci"},{"issue":"573","key":"698_CR15","doi-asserted-by":"publisher","first-page":"eabe2555","DOI":"10.1126\/scitranslmed.abe2555","volume":"12","author":"A Popa","year":"2020","unstructured":"Popa A, Genger J-W, Nicholson MD, Penz T, Schmid D, Aberle SW, Agerer B, Lercher A, Endler L, Cola\u00e7o H, Smyth M, Schuster M, Grau ML, Mart\u00ednez-Jim\u00e9nez F, Pich O, Borena W, Pawelka E, Keszei Z, Senekowitsch M, Laine J, Aberle JH, Redlberger-Fritz M, Karolyi M, Zoufaly A, Maritschnik S, Borkovec M, Hufnagl P, Nairz M, Weiss G, Wolfinger MT, von Laer D, Superti-Furga G, Lopez-Bigas N, Puchhammer-St\u00f6ckl E, Allerberger F, Michor F, Bock C, Bergthaler A (2020) Genomic epidemiology of superspreading events in Austria reveals mutational dynamics and transmission properties of SARS-CoV-2. Sci Transl Med 12(573):eabe2555. https:\/\/doi.org\/10.1126\/scitranslmed.abe2555","journal-title":"Sci Transl Med"},{"key":"698_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2020-206751","author":"D Payne","year":"2020","unstructured":"Payne D, Newton D, Evans P, Osman H, Baretto R (2020) Preanalytical issues affecting the diagnosis of COVID-19. J Clin Pathol. https:\/\/doi.org\/10.1136\/jclinpath-2020-206751","journal-title":"J Clin Pathol"},{"issue":"10","key":"698_CR17","doi-asserted-by":"publisher","first-page":"e00711","DOI":"10.1128\/jcm.00711-18","volume":"56","author":"DA Green","year":"2018","unstructured":"Green DA, StGeorge K (2018) Rapid antigen tests for influenza: rationale and significance of the FDA reclassification. J Clin Microbiol 56(10):e00711-00718. https:\/\/doi.org\/10.1128\/jcm.00711-18","journal-title":"J Clin Microbiol"},{"issue":"11","key":"698_CR18","doi-asserted-by":"publisher","first-page":"e02225","DOI":"10.1128\/jcm.02225-20","volume":"58","author":"MA Pettengill","year":"2020","unstructured":"Pettengill MA, McAdam AJ (2020) Can we test our way out of the COVID-19 pandemic? J Clin Microbiol 58(11):e02225-e12220. https:\/\/doi.org\/10.1128\/jcm.02225-20","journal-title":"J Clin Microbiol"},{"key":"698_CR19","unstructured":"Robert Koch Institut. Nationale Teststrategie\u2014wer wird in Deutschland auf das Vorliegen einer SARS-CoV-2 Infektion getestet? https:\/\/www.rki.de\/DE\/Content\/InfAZ\/N\/Neuartiges_Coronavirus\/Teststrategie\/Nat-Teststrat.html. Accessed 26 Nov 2020"}],"container-title":["Medical Microbiology and Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-020-00698-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00430-020-00698-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-020-00698-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T01:04:13Z","timestamp":1614301453000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00430-020-00698-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,16]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["698"],"URL":"https:\/\/doi.org\/10.1007\/s00430-020-00698-8","relation":{},"ISSN":["0300-8584","1432-1831"],"issn-type":[{"value":"0300-8584","type":"print"},{"value":"1432-1831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,16]]},"assertion":[{"value":"4 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval was not required because all samples used were residual samples. Samples were identified in the laboratory and assigned a number without reference to patient or clinical details. Results from testing using the study assays did not impact on clinical care.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}